Stockscreener 앱 받기
5.49
8.50%
-0.51
전일 마감가:
$6.00
열려 있는:
$5.9
하루 거래량:
104.64K
Relative Volume:
0.21
시가총액:
$6.46M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-58.91%
1개월 성능:
-28.79%
6개월 성능:
-88.24%
1년 성능:
+0.00%
1일 변동 폭
$5.46
$5.9344
1주일 범위
$5.46
$14.06
52주 변동 폭
$5.46
$121.80
Autonomix Medical Inc Stock (AMIX) Company Profile
명칭
Autonomix Medical Inc
전화
832-277-7816
주소
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
AMIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
5.49 | 6.46M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Autonomix Medical Inc 주식(AMIX)의 최신 뉴스
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option - The Manila Times
Autonomix Medical, Inc. Announces Closing of $10.0 Million - GlobeNewswire
Autonomix Medical Closes $10M Public Offering with Warrants to Fund Clinical Trials | AMIX Stock News - StockTitan
Autonomix Medical stock dips after pricing $9M securities offering - MSN
Autonomix Medical (NASDAQ:AMIX) vs. Perspective Therapeutics (NYSE:CATX) Critical Review - Defense World
Autonomix Medical (AMIX) & Its Rivals Head to Head Contrast - Defense World
Autonomix Medical Prices of $9.0 Million Underwritten Public Offering - citybiz
Autonomix Medical Down 53% After Pricing of $9M Offering - MarketWatch
Crude Oil Gains Over 1%; Ross Stores Earnings Top Views - Benzinga
Stock market news: Dragonfly Energy Holdings -88.31%, Autonomix Medical -53.33% among top stock losers during mid day trading - Business Upturn
Autonomix Medical slumps after $9 mln stock offering - XM
Stock market today: Dragonfly Energy Holdings -88.07%, Autonomix Medical -52.37% among top losers in early trading - Business Upturn
Dow Jumps 300 Points; Gap Posts Upbeat Earnings - Benzinga
Autonomix to sell 1.38M units at $6.54 in underwritten public offering - TipRanks
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering - GlobeNewswire
Autonomix Medical Prices $9M Public Offering with Warrants to Fund Clinical Trials | AMIX Stock News - StockTitan
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket - Benzinga
A.M.AUTONOMY Showcases MAP-TORCH for 3D Construction Digitalization at KINTEX - GlobeNewswire Inc.
Autonomix Medical reports net loss of USD 2.8M in 3 months - Medical Buyer
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update - The Manila Times
Autonomix reports Q2 incurred net losses $2.8M vs $6M last year - TipRanks
Autonomix Medical Inc (AMIX) Quarterly 10-Q Report - Quartz
Autonomix Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Autonomix reports results from first 15 patients’ data on transvascular energy - MSN
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Autonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain Treatment - MarketWatch
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - BioSpace
Autonomix (AMIX) Gains Investor Confidence After Encouraging Trial Results - Stocks Telegraph
Autonomix Medical, Inc. Reports New Positive Topline - GlobeNewswire
Autonomix Medical (AMIX) Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses - GlobeNewswire
Autonomix participates in Virtual Investor ‘What This Means’ segment - TipRanks
AMIS Stock Surges After RF Ablation Trial Unveils Positive Results - MSN
Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest - Defense World
Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention - Barchart
Autonomix announces preliminary results from trial on ablation technology - TipRanks
Autonomix Shares Soar 85% on Results From Pain-Management Study - MarketWatch
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher - Benzinga
Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday? - Benzinga
Autonomix (AMIX) Stock Soars On Positive Pain Management Trial Outcomes - Stocks Telegraph
Autonomix jumps after its treatment reduces pain during trial - XM
Autonomix reports breakthrough in pancreatic cancer pain - Investing.com India
Positive Preliminary Results Demonstrate Autonomix's Proprietary RF Ablation Technology's Ability to Reduce Opioid Use in Ongoing Human Clinical Trial - The Manila Times
Positive Preliminary Results Demonstrate Autonomix’s - GlobeNewswire
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial - StockTitan
1,518,000 Common Stock of Autonomix Medical, Inc. are subject to a Lock-Up Agreement Ending on 27-OCT-2024. - Marketscreener.com
Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th - GlobeNewswire
Autonomix Medical to conduct a reverse stock split - MSN
Autonomix Medical announces 1-for-20 reverse stock split By Investing.com - Investing.com Nigeria
Nerve ablation tech developer Autonomix to effect a reverse stock split - Mass Device
Autonomix Announces Reverse Stock Split - citybiz
Autonomix Medical Inc (AMIX) 재무 분석
Autonomix Medical Inc (AMIX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):